Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
COCO reported proposed and recent insider sales of Common stock by Martin F. Roper. The filing lists an intended sale of 25,000 shares (Option granted 09/19/2019) for cash on 04/16/2026, and multiple actual sales in early April 2026 totaling several 25,000-share blocks and one 4,456-share sale with aggregate proceeds shown for each trade.
COCO filed a Form 144 notice for the proposed sale of 25,000 shares of Common Stock (option granted 09/19/2019), with the proposed sale dated 04/15/2026. The excerpt also lists multiple recent open-market sales by Martin F. Roper totaling several transactions in April 2026.
Vita Coco Company, Inc. CEO Martin Roper exercised stock options and sold the resulting shares. He exercised options for 29,456 shares of common stock at an exercise price of $10.178 per share, then sold 29,456 shares in open-market trades at weighted average prices around $50-$51.10 under a Rule 10b5-1 trading plan. After these transactions, he directly holds 298,484 common shares, alongside additional indirect holdings through family trusts and his spouse.
Martin Roper submitted a Form 144 notice proposing the sale of 25,000 shares of Common Stock (aggregate $1,250,000.00) through Fidelity Brokerage Services LLC on 04/14/2026. The filing also lists recent sales executed 04/07/2026 (25,000 for $1,250,000.00), 04/08/2026 (25,000 for $1,273,740.00), 04/10/2026 (25,000 for $1,252,680.00), and 04/13/2026 (4,456 for $225,248.13).
COCO reported officer/affiliate sales under Rule 144. Martin Roper furnished notices for three open-market dispositions of Common stock: 25,000 shares on 04/07/2026 for $1,250,000, 25,000 shares on 04/08/2026 for $1,273,740, and 25,000 shares on 04/10/2026 for $1,252,680. The filing lists Fidelity Brokerage Services LLC as a broker and references an option granted on 09/19/2019.
The Vita Coco Company, Inc. announced that board member John Leahy will retire from its Board of Directors and will not stand for reelection at the Company’s 2026 Annual Meeting of Stockholders on June 3, 2026. He has served on the Board since 2019 and is a member of both the Audit Committee and the Compensation Committee, continuing in these roles until his term ends at the meeting. The Company states that Mr. Leahy’s decision is solely for personal reasons and not due to any disagreement over operations, policies, or practices. After his retirement, the Board’s size will decrease from ten members to nine.
COCO reported proposed and recent Section 144 sales of common stock. The filing lists a proposed sale of 25,000 shares on 04/10/2026 tied to an Option Granted - 09/19/2019 with cash settlement. It also records two recent sales by Martin Roper: 25,000 shares on 04/07/2026 for $1,250,000 and 25,000 shares on 04/08/2026 for $1,273,740.
Vita Coco Company, Inc. chief executive Martin Roper exercised stock options and sold shares in coordinated transactions. On April 7 and 8, he exercised options to acquire a total of 50,000 shares of common stock at an exercise price of $10.178 per share, then sold 50,000 shares in open-market trades at weighted average prices of approximately $50.00 and $50.949 per share. After these transactions, he directly holds 298,484 common shares and retains multiple blocks of non-qualified stock options with exercise prices ranging from $10.178 to $32.780 per share. The sales were made under a pre-arranged Rule 10b5-1 trading plan.
Martin Roper reported a proposed sale of 25,000 shares of Common Stock of COCO. The filing shows a sale dated 04/07/2026 with proceeds of $1,250,000.00 and a related broker entry for 25,000 shares through Fidelity Brokerage Services LLC on 04/08/2026. An option grant date of 09/19/2019 is noted.
BlackRock, Inc. amended a Schedule 13G/A to report beneficial ownership of 6,634,636 shares of The Vita Coco Company Inc (Common Stock), representing 11.6% of the class as stated in the filing. The amendment attributes ownership to certain Reporting Business Units of BlackRock and shows 6,555,826 shares of sole voting power and 6,634,636 shares of sole dispositive power. The filing lists BlackRock's address and includes Exhibits 24 and 99 and is signed by a Managing Director on 04/07/2026.